Sort by
Search results
BIOPHEN Heparin 3
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN DiXaI (Direct Xa Inhibitors)
Measurement of rivaroxaban and other factor Xa inhibitors in citrated plasma or other biological fluids. Note: BIOPHEN Heparin LRT and BIOPHEN Heparin (3 or 6) can also be used for testing direct factor Xa inhibitors (DiXaIs), such as rivaroxaban, apixaban or edoxaban. Adjusted protocols are available on demand.
BIOPHEN Antithrombin 5 (anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin 2.5 (Anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN α2-Antiplasmin (Plasmin Inhibitor) LRT
Assay proposed for the measurement of plasmin inhibitor (α2-antiplasmin) activity in research applications.
BIOPHEN Factor V-L Control Plasma
Quality control plasma for the qualitative or quantitative assay of FV-Leiden (resistant to APC), with clotting assays (e.g. HEMOCLOT Factor V-L, HEMOCLOT Quanti. VL).
BIOPHEN Factor V-L Plasma Calibrator
Calibration of HEMOCLOT Quanti. VL kit (CK065K).
BIOPHEN Normal Plasma (Poolplasma, non-titrated)
Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.
BIOPHEN Normal Plasma (Poolplasma, non-titrated)
Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.
BIOPHEN Plasminogen LRT
Assay of plasminogen in human plasma for the diagnosis of congenital or acquired plasminogen deficiencies. An abnormal plasminogen activity is an indicator for fibrinolytic troubles.